HERG - PDFSEARCH.IO - Document Search Engine

HERG
Results: 73

#	Item
31	In Silico Models for Screening New Drugs for QT Prolongation Potential using Human Clinical Trial Data OpenTox USA 2013 Innovation in Predictive Toxicology October 30, 2013 Add to Reading List Source URL: www.opentox.org Language: English - Date: 2014-02-05 08:06:48 Physiology QT interval Long QT syndrome Torsades de pointes HERG Proarrhythmia Ventricular tachycardia Moxifloxacin Cardiac dysrhythmia Health Chemistry
32	Briefing Package - Errata Add to Reading List Source URL: www.fda.gov Language: English Medicinal chemistry Pharmacology HERG Rifaximin IC50 In vitro Medicine Chemistry Pharmaceutical sciences Ion channels
33	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Antitussives Dextropropoxyphene Propionates Medicine Pharmacology HERG Digital Picture Exchange Chemistry Eli Lilly and Company Amines
34	L. Steven Leshin: Pharmacology and Toxicology Add to Reading List Source URL: www.fda.gov Language: English Amines Eli Lilly and Company Pharmacology Anesthesia Dextropropoxyphene HERG Local anesthetic Receptor antagonist Analgesic Chemistry Medicine Organic chemistry
35	Docket 04D-0377, ICH E a , linical Evaluation of QT Prolonga iat Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation ATTACHMENT Page 14 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-12-27 14:03:22 Chemistry Biology QT interval Channelopathy Syndromes HERG Long QT syndrome Torsades de pointes Electrocardiography Cardiac dysrhythmia Cardiac electrophysiology Physiology
36	0 (#I@Bristol-Myers Squibb Company Richard L. W uth, Ph.D. Senior Vice President Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:56 Circulatory system Health Purkinje fibers Dofetilide Proarrhythmia HERG Cardiac electrophysiology Physiology QT interval
37	Pfizer Inc Worldwide Regulatory Affairs and Quality Assurance 50 Pequot Avenue New London, Connecticut[removed]I . Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:56 HERG Medicinal chemistry Pharmacology Biology Syndromes QT interval Long QT syndrome Cardiac dysrhythmia Health Medicine
38	Schering-Plough Research Institute . I Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:55 Cardiac electrophysiology Circulatory system Pharmacology QT interval HERG Torsades de pointes In vivo Pre-clinical development Myocardial infarction Medicine Health Cardiac dysrhythmia
39	,,‘ /II,” A’ December 13,2004 Management Dockets, N/A Add to Reading List Source URL: www.fda.gov Language: English Medicinal chemistry Research Information Drug discovery Clinical research QT interval Comment Nonclinical studies Science Pharmacology Ion channels HERG
40	Guidance for Industry S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-10-17 17:55:35 Health Cardiac electrophysiology Pharmacology Ion channels Syndromes HERG QT interval Long QT syndrome Torsades de pointes Biology Cardiac dysrhythmia Medicine